Can PET-MRI spot hidden brain tumors in kids?
NCT ID NCT05553899
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing whether a combined PET-MRI scan can better detect if a child's brain tumor has returned after treatment. The study will include 5 children with high-grade gliomas or medulloblastomas who have unclear results from standard MRI. The main goal is to see if such a study is feasible, not yet to prove the method works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PET-MRI with 18F-FDG tracer
- What this could lead to
- If successful, this could show that PET-MRI is a better way to spot tumor recurrence in children, potentially improving follow-up care.
- What could go wrong
- This is a very small pilot study with only 5 participants, so results may not apply widely. It is testing feasibility, not effectiveness, and may not lead to changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, PEDIATRIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheffield Children's Hospital
RECRUITINGSheffield, South Yorkshire, S10 1SN, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can the Body's own immune cells beat a recurrent brain tumor?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?
- Can AI read tumor slides to outsmart childhood cancer?